Fulcrum Therapeutics, Inc. (FULC)

NASDAQ: FULC · Real-Time Price · USD

12.80

-1.00 (-7.25%)

At close: Dec 11, 2025, 4:00 PM EST

13.02

+0.22 (1.72%)

After-hours: Dec 11, 2025, 6:33 PM EST

Fulcrum Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '25 Dec 11, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Market Capitalization	693	254	417	379	717	319	Upgrade
Market Cap Growth	295.16%	-39.25%	10.13%	-47.15%	124.42%	-14.89%	Upgrade
Enterprise Value	509	5	172	171	477	192	Upgrade
Last Close Price	13.80	4.70	6.75	7.28	17.69	11.71	Upgrade
PS Ratio	-	3.17	148.77	59.75	37.41	36.21	Upgrade
PB Ratio	3.76	1.04	1.77	1.91	3.39	3.36	Upgrade
P/TBV Ratio	3.54	1.04	1.77	1.91	3.39	3.36	Upgrade
EV/Sales Ratio	-	0.07	61.21	26.99	24.87	21.82	Upgrade
Debt / Equity Ratio	0.04	0.04	0.05	0.07	-	0	Upgrade
Asset Turnover	-	0.31	0.01	0.03	0.11	0.07	Upgrade
Quick Ratio	17.33	22.13	17.44	12.20	11.58	4.33	Upgrade
Current Ratio	17.70	22.63	17.71	12.41	11.77	4.47	Upgrade
Return on Equity (ROE)	-31.21%	-4.07%	-44.84%	-53.53%	-52.72%	-77.68%	Upgrade
Return on Assets (ROA)	-20.63%	-4.78%	-28.56%	-30.36%	-27.79%	-37.30%	Upgrade
Return on Capital (ROIC)	-21.59%	-4.98%	-30.18%	-33.07%	-33.03%	-49.08%	Upgrade
Return on Capital Employed (ROCE)	-40.10%	-7.90%	-45.40%	-53.40%	-37.60%	-69.60%	Upgrade
Earnings Yield	-10.12%	-3.84%	-23.33%	-28.99%	-11.28%	-22.17%	Upgrade
FCF Yield	-8.60%	-0.98%	-21.92%	-26.13%	-11.19%	-17.21%	Upgrade
Buyback Yield / Dilution	-0.19%	-1.10%	-36.27%	-27.23%	-39.47%	-129.53%	Upgrade

Updated Oct 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q